455 related articles for article (PubMed ID: 17517971)
1. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
[TBL] [Abstract][Full Text] [Related]
2. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
3. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
4. Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD.
Goodship TH
Kidney Int; 2006 Jul; 70(1):12-3. PubMed ID: 16810287
[TBL] [Abstract][Full Text] [Related]
5. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
Geerlings MJ; Volokhina EB; de Jong EK; van de Kar N; Pauper M; Hoyng CB; van den Heuvel LP; den Hollander AI
Clin Genet; 2018 Oct; 94(3-4):330-338. PubMed ID: 29888403
[TBL] [Abstract][Full Text] [Related]
7. The development of atypical hemolytic uremic syndrome depends on complement C5.
de Jorge EG; Macor P; Paixão-Cavalcante D; Rose KL; Tedesco F; Cook HT; Botto M; Pickering MC
J Am Soc Nephrol; 2011 Jan; 22(1):137-45. PubMed ID: 21148255
[TBL] [Abstract][Full Text] [Related]
8. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
9. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.
Rose KL; Paixao-Cavalcante D; Fish J; Manderson AP; Malik TH; Bygrave AE; Lin T; Sacks SH; Walport MJ; Cook HT; Botto M; Pickering MC
J Clin Invest; 2008 Feb; 118(2):608-18. PubMed ID: 18202746
[TBL] [Abstract][Full Text] [Related]
10. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
de Córdoba SR; de Jorge EG
Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
[TBL] [Abstract][Full Text] [Related]
11. Complement and diseases: defective alternative pathway control results in kidney and eye diseases.
Zipfel PF; Heinen S; Józsi M; Skerka C
Mol Immunol; 2006 Jan; 43(1-2):97-106. PubMed ID: 16026839
[TBL] [Abstract][Full Text] [Related]
12. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.
Wong EKS; Hallam TM; Brocklebank V; Walsh PR; Smith-Jackson K; Shuttleworth VG; Cox TE; Anderson HE; Barlow PN; Marchbank KJ; Harris CL; Kavanagh D
Front Immunol; 2020; 11():602284. PubMed ID: 33519811
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
14. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
16. Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.
Ueda Y; Miwa T; Gullipalli D; Sato S; Ito D; Kim H; Palmer M; Song WC
J Am Soc Nephrol; 2018 Jul; 29(7):1928-1937. PubMed ID: 29858280
[No Abstract] [Full Text] [Related]
17. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
[TBL] [Abstract][Full Text] [Related]
18. Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.
Recalde S; Tortajada A; Subias M; Anter J; Blasco M; Maranta R; Coco R; Pinto S; Noris M; García-Layana A; Rodríguez de Córdoba S
J Am Soc Nephrol; 2016 May; 27(5):1305-11. PubMed ID: 26376859
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H and the hemolytic uremic syndrome.
Atkinson JP; Goodship TH
J Exp Med; 2007 Jun; 204(6):1245-8. PubMed ID: 17548524
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.
Clark SJ; Ridge LA; Herbert AP; Hakobyan S; Mulloy B; Lennon R; Würzner R; Morgan BP; Uhrín D; Bishop PN; Day AJ
J Immunol; 2013 Mar; 190(5):2049-57. PubMed ID: 23365078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
